Financhill
Buy
58

UTHR Quote, Financials, Valuation and Earnings

Last price:
$314.18
Seasonality move :
3.89%
Day range:
$304.55 - $324.22
52-week range:
$221.53 - $417.82
Dividend yield:
0%
P/E ratio:
13.13x
P/S ratio:
5.45x
P/B ratio:
2.25x
Volume:
400.6K
Avg. volume:
555.4K
1-year change:
36.97%
Market cap:
$14.5B
Revenue:
$2.9B
EPS (TTM):
$24.60

United Therapeutics SEC Filings

Company Filed Form Type Description
UTHR
United Therapeutics
05/01/2024 10-Q 10-Q filing on 05/01/2024 View Form
UTHR
United Therapeutics
11/01/2023 10-Q 10-Q filing on 11/01/2023 View Form
UTHR
United Therapeutics
08/02/2023 10-Q 10-Q filing on 08/02/2023 View Form
UTHR
United Therapeutics
05/03/2023 10-Q 10-Q filing on 05/03/2023 View Form
UTHR
United Therapeutics
11/02/2022 10-Q 10-Q filing on 11/02/2022 View Form
UTHR
United Therapeutics
08/03/2022 10-Q 10-Q filing on 08/03/2022 View Form
UTHR
United Therapeutics
05/04/2022 10-Q 10-Q filing on 05/04/2022 View Form
UTHR
United Therapeutics
11/03/2021 10-Q 10-Q filing on 11/03/2021 View Form
UTHR
United Therapeutics
08/04/2021 10-Q 10-Q filing on 08/04/2021 View Form
UTHR
United Therapeutics
05/05/2021 10-Q 10-Q filing on 05/05/2021 View Form
UTHR
United Therapeutics
10/28/2020 10-Q 10-Q filing on 10/28/2020 View Form
UTHR
United Therapeutics
07/29/2020 10-Q 10-Q filing on 07/29/2020 View Form
UTHR
United Therapeutics
04/29/2020 10-Q 10-Q filing on 04/29/2020 View Form
UTHR
United Therapeutics
02/26/2020 10-K 10-K filing on 02/26/2020 View Form
UTHR
United Therapeutics
10/30/2019 10-Q 10-Q filing on 10/30/2019 View Form
UTHR
United Therapeutics
07/31/2019 10-Q 10-Q filing on 07/31/2019 View Form
UTHR
United Therapeutics
05/01/2019 10-Q 10-Q filing on 05/01/2019 View Form
UTHR
United Therapeutics
02/27/2019 10-K 10-K filing on 02/27/2019 View Form
UTHR
United Therapeutics
10/31/2018 10-Q 10-Q filing on 10/31/2018 View Form
UTHR
United Therapeutics
08/01/2018 10-Q 10-Q filing on 08/01/2018 View Form
UTHR
United Therapeutics
05/02/2018 10-Q 10-Q filing on 05/02/2018 View Form
UTHR
United Therapeutics
02/21/2018 10-K 10-K filing on 02/21/2018 View Form
UTHR
United Therapeutics
10/25/2017 10-Q 10-Q filing on 10/25/2017 View Form
UTHR
United Therapeutics
07/27/2017 10-Q 10-Q filing on 07/27/2017 View Form
UTHR
United Therapeutics
04/26/2017 10-Q 10-Q filing on 04/26/2017 View Form
UTHR
United Therapeutics
02/22/2017 10-K 10-K filing on 02/22/2017 View Form
UTHR
United Therapeutics
10/27/2016 10-Q 10-Q filing on 10/27/2016 View Form
UTHR
United Therapeutics
07/28/2016 10-Q 10-Q filing on 07/28/2016 View Form
UTHR
United Therapeutics
04/28/2016 10-Q 10-Q filing on 04/28/2016 View Form
UTHR
United Therapeutics
02/25/2016 10-K 10-K filing on 02/25/2016 View Form
UTHR
United Therapeutics
10/27/2015 10-Q 10-Q filing on 10/27/2015 View Form
UTHR
United Therapeutics
07/28/2015 10-Q 10-Q filing on 07/28/2015 View Form
UTHR
United Therapeutics
04/28/2015 10-Q 10-Q filing on 04/28/2015 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
52
RGC alert for Mar 18

Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.

Buy
63
EXOD alert for Mar 18

Exodus Movement [EXOD] is down 3.96% over the past day.

Sell
45
MNPR alert for Mar 18

Monopar Therapeutics [MNPR] is up 0.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock